When does quality-adjusting life-years matter in cost-effectiveness analysis?
about
Is complementary and alternative medicine (CAM) cost-effective? A systematic review.Does Medicare have an implicit cost-effectiveness threshold?Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions?Impact of discussion on preferences elicited in a group setting.Measuring preferences for cost-utility analysis: how choice of method may influence decision-makingPredicting health utilities for children with autism spectrum disorders.Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1.Cost-effectiveness analysis of a low-fat diet in the prevention of breast and ovarian cancerValue-based medicine: concepts and applicationThe value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible.Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescentsEstimation of utilities for chronic hepatitis C from SF-36 scores.Contemporary quality of life issues affecting gynecologic cancer survivors.The Evolution of Teleophthalmology Programs in the United Kingdom: Beyond Diabetic Retinopathy ScreeningCost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington StateCost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer.Decision Analysis and Cost-effectiveness Analysis.A systematic review of the key indicators for assessing telehomecare cost-effectiveness.Surgical treatment for adult spinal deformity: projected cost effectiveness at 5-year follow-up.The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications.Cost utility analyses in international disaster responses-where are they?Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
P2860
Q24816198-29F26459-646D-4751-8D0A-77CD6CAB2170Q34121002-4906E0BE-907A-4AB7-9985-E6842F694253Q34166892-FDECD8FA-517B-40CC-81DA-DB583AE866B8Q34547451-A8CC1649-F31D-4696-8EB4-BBF9BDAEF3A6Q34614168-D7F53E4D-BA39-4917-829A-7F15E50E47F4Q34735353-53A80E78-AB6D-43F1-8C9D-84E50F2B380DQ35002445-EACDBA7B-373C-48A6-AF46-C69388038876Q35237983-9699E102-0C09-43C4-ACCC-B7670C4FF405Q35438629-31F4CD2C-7762-47B3-A2EC-E36C75CDA52EQ35967155-2F15C32F-42A0-445B-9E95-821A0442856AQ36002613-1BAD15B3-D4D9-44E3-8B1F-80484859CBA3Q36060018-833031D3-ED7F-4CCA-9801-C64853EDF3FDQ36067725-4087FFFC-3B42-46D3-B19A-79ADE68DAAEAQ36638958-13A59FDD-5666-4291-B5AB-48FC196149A0Q36839938-181006EE-0827-4085-AC29-8AC3FFEB57CBQ36944056-A6595AAA-5ABF-4A18-9733-41C350555422Q37103589-8654C7D1-CE81-43BA-A5CE-3765E1E6C4CDQ37335410-D42BB37F-6816-4BB9-804D-43D4BEC19EBDQ37655385-FD9602EB-9590-42D3-9761-85D641BEC7D9Q37887568-76810D61-4D74-49B7-8755-52140698828BQ38010925-3052DCAB-2007-4047-A88F-152DBC1D3A56Q40274165-73CEA2EC-9D17-403D-A6BE-AF6B9BEC5D3FQ50873130-973881BA-FC75-4801-AE9C-B2593CC749C1Q58635831-F4164DCB-BB26-468A-B6B9-1CD4C8B6E38A
P2860
When does quality-adjusting life-years matter in cost-effectiveness analysis?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
When does quality-adjusting life-years matter in cost-effectiveness analysis?
@ast
When does quality-adjusting life-years matter in cost-effectiveness analysis?
@en
type
label
When does quality-adjusting life-years matter in cost-effectiveness analysis?
@ast
When does quality-adjusting life-years matter in cost-effectiveness analysis?
@en
prefLabel
When does quality-adjusting life-years matter in cost-effectiveness analysis?
@ast
When does quality-adjusting life-years matter in cost-effectiveness analysis?
@en
P2093
P356
P1433
P1476
When does quality-adjusting life-years matter in cost-effectiveness analysis?
@en
P2093
Jane C Weeks
Marc Berger
Peter J Neumann
Richard H Chapman
P304
P356
10.1002/HEC.853
P407
P577
2004-05-01T00:00:00Z